The issue of comparators in economic evaluations of biologic response modifiers in rheumatoid arthritis
Introduction Over the last decade, a number of biologic response modifiers (BRMs) have emerged and transformed rheumatoid arthritis (RA) management. Due to their relatively high costs, economic evaluations have attempted…